We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Last week, Sen. Charles Grassley, R-Iowa, vowed to haul pharma CEOs into Senate hearings on drug prices. Now, CEOs for Merck, Pfizer, Sanofi, Bristol-Myers Squibb and AbbVie have heeded the call.